Nitric oxide protects blood-brain barrier in vitro from hypoxia/reoxygenation-mediated injury  by Utepbergenov, Darkhan I et al.
Nitric oxide protects blood-brain barrier in vitro from
hypoxia/reoxygenation-mediated injury
Darkhan I. Utepbergenova, Katharina Mertschb, Anje Sporbertb, Kareen Tenzb, Martin Paulc,
Reiner F. Haselo¡b, Ingolf E. Blasigb;*
aInstitute of Chemical Kinetics and Combustion, Novosibirsk 630090, Russia
bForschungsinstitut fuºr Molekulare Pharmakologie, Alfred-Kowalke-Str. 4, D-10315 Berlin, Germany
cInstitut fuºr Klinische Pharmakologie, Freie Universitaºt, 12200 Berlin, Germany
Received 10 February 1998
Abstract A cell culture model of blood-brain barrier (BBB,
coculture of rat brain endothelial cells with rat astrocytes) was
used to investigate the effect of nitric oxide (cNO) on the damage
of the BBB induced by hypoxia/reoxygenation (H/R). Perme-
ability coefficient of fluorescein across the endothelium was used
as a marker of BBB tightness. The permeability coefficient
increased 5.2 times after H/R indicating strong disruption of the
BBB. The presence of the cNO donor S-nitroso-N-acetylpeni-
cillamine (SNAP, 30 WM), authentic cNO (6 WM) or superoxide
dismutase (50 units/ml) during H/R attenuated H/R-induced
increase in permeability. 30 WM SNAP or 6 WM cNO did not
influence the function of BBB during normoxia, however, severe
disruption was observed using 150 WM of SNAP and more than
24 WM of cNO. After H/R of endothelial cells, the content of
malondialdehyde (MDA) increased 2.3 times indicating radical-
induced peroxidation of membrane lipids. 30 WM SNAP or 6 WM
authentic cNO completely prevented MDA formation. The
results show that cNO may effectively scavenge reactive oxygen
species formed during H/R of brain capillary endothelial cells,
affording protection of BBB at the molecular and functional
level.
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1. Introduction
Nitric oxide (cNO) is known to serve as a messenger, main-
taining di¡erent physiological and biochemical processes, es-
pecially by modulating the cellular content of cyclic GMP [1].
cNO may also cause cell and tissue injury [2], in particular by
inhibiting the mitochondrial respiration chain leading to an
increase in the rate of superoxide radical generation [3]. On
the other hand, it has been reported that cNO directly protects
membranes in various pathological situations, especially
under conditions of increased rates of radical generation,
such as Cu2- or lipoxygenase-induced lipid peroxidation
[4,5]. cNO has been reported to participate in the detoxi¢ca-
tion of peroxynitrite (ONOO3) and hydrogen peroxide
(H2O2) [6,7]. Thus, cNO exerts both damaging and protective
e¡ects. Therefore, more information is required to de¢ne the
physiological and pathophysiological conditions that deter-
mine whether cNO acts in a protective or a toxic manner [8].
The penetration of hydrophilic substances into and out of
the brain is strictly regulated by the blood-brain barrier
(BBB). The restricted permeability of this barrier, formed by
brain capillary endothelial cells, is a decisive condition for
maintaining the integrity of the brain. The BBB is disturbed
under various pathological conditions including hypoxia/re-
oxygenation (H/R) [9]. Oxygen free radicals are suggested to
play a crucial role in the disturbance of the endothelial barrier
function under H/R [10]. Nitric oxide production increases in
ischemic brain [11]. Recently, the destructive role of endoge-
nous cNO has been demonstrated in the damage of the BBB
during acute hypertension [12] or after excessive glutamate
administration [13]. However, little is known about the mech-
anisms of cNO a¡ecting BBB.
In this study, the e¡ect of exogenous cNO was investigated
using a cell culture model of BBB injured by H/R. The data
obtained support the view that, under conditions of increased
radical production, excess of cNO may e¡ectively detoxify
reactive oxygen species. This detoxi¢cation may prevent mem-
brane lipid peroxidation and disruption of BBB caused by
H/R.
2. Materials and methods
2.1. Reagents
S-nitroso penicillamine (SNAP) was purchased from Calbiochem.
Immediately after dilution, aliquots of 8 mM solution were frozen in
liquid nitrogen. Solutions were thawed immediately before use. Super-
oxide dismutase (SOD) was obtained from Sigma. Nitric oxide solu-
tions were obtained and puri¢ed as described previously [14].
2.2. Cell culture
Cloned immortalized rat brain endothelial cells (RBE4 [15], kindly
supplied by Prof. P.O. Couraud, Paris, France), were cultivated in
HAM’s F10/K-medium 1:1, 10% fetal bovine serum (FBS), 2 mM
glutamine, 1 ng/ml bovine ¢broblast growth factor (bFGF), 300 Wg/
ml geneticin (Boehringer Mannheim). Primary rat brain capillary en-
dothelial cells were isolated and cultivated as described [16]. Astro-
cytes from neonatal rats were cultivated in DMEM with 10% FBS,
2 mM glutamine, 100 IU/ml penicillin, 100 Wg/ml streptomycin, 2.5
Wg/ml amphotericin B (Biochrom) [9]. To establish an in vitro BBB
model, RBE4 were cultivated on ¢lter inserts (polyethylene terephtha-
late, 0.45 Wm pore size, 1.6U106 pores/cm2, Falcon; coated with rat
tail collagen I); astrocytes were seeded in 6-well plates containing ¢lter
inserts with RBE4.
2.3. Assay of sGC mRNA
The expression of soluble guanylate cyclase (sGC) mRNA (subunits
K1, L1, K2, L2) was investigated by means of reverse transcription
polymerase chain reaction (RT-PCR) in primary rat brain capillary
endothelial cells, rat astrocytes and RBE4. Total cellular RNA was
isolated using TRIzol reagent (Gibco-BRL) according to the manu-
facturer’s instructions. Total RNA concentration was estimated by
UV absorbance at 260 nm. The ¢rst-strand cDNA was synthesized
by reverse transcription with 200 U MMLV-RT (Gibco-BRL) per Wg
RNA and 5 WM random hexamers. Control PCR assays were per-
formed using speci¢c primers to rat L-actin [17] as an external stand-
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ard. The presence of sGC subunits was examined by speci¢c primers
to K1 subunit and L1 subunit [18] and to K2 subunit and L2 subunit
[19]. cDNA was ampli¢ed (25^35 cycles) at 95‡C for 30 s, 60‡C for
1 min, 72‡C for 30 s for L-actin and 95‡C for 30 s, 58‡C for 1.5 min,
72‡C for 1 min for sGC (melting, annealing and extension temper-
atures, respectively). Phage PX174 RF DNA digested with HaeIII was
used as molecular weight standard.
2.4. Hypoxia/reoxygenation experiments
To study the e¡ect of H/R on malondialdehyde (MDA) content
con£uent monolayers of RBE4 cells cultivated on 6-well plates (Fal-
con) were washed twice with phosphate bu¡ered solution (PBS, with
Ca2, Mg2, glucose-free, pH 7.2, Biochrom), then 1 ml of PBS sat-
urated with Nelson gas (95% N2/5% CO2) was added to each well.
Cells were gassed for 120 min in an incubator at 37‡C with Nelson gas
to produce hypoxia. Reoxygenation was started by gassing the cells
with Carbogen (95% O2/5% CO2) for 60 min. Since SNAP solutions
have a short half-life, 15 or 30 Wl of a 1 mM SNAP solution was
added twice during reoxygenation time (at 0 and 30 min) to each well
to a¡ord the presence of cNO during reoxygenation. Similarly, 10 Wl
of 100 WM of authentic cNO solution was added six times every 10
min, starting from 0 min of reoxygenation.
To study the e¡ect of H/R on permeability, ¢lters of RBE4 cells
cocultivated with primary astrocytes (BBB model) were put into the 6-
well plates containing 1 ml PBS saturated with Nelson gas, then 1 ml
of PBS was added into each ¢lter. Duration of hypoxia and reoxyge-
nation was 60 min and 30 min, respectively. 10 Wl of 1 mM SNAP
solution was added every 30 min (at 0 and 30 min of hypoxia and at
0 min of reoxygenation) to each well to a¡ord the presence of cNO
during both hypoxia and reoxygenation. Similarly, 10 Wl of 100 WM of
authentic cNO solution was added three times (every 20 min) during
hypoxia and three times during reoxygenation (every 10 min). Oxygen
tension under conditions of hypoxia was 25^30 mm Hg. pH of PBS
saturated with Nelson gas was corrected to 7.2 by addition of KOH.
To study the e¡ect of di¡erent concentrations of cNO and SNAP on
BBB permeability under normoxic conditions, aliquots of SNAP and
cNO were added to the ¢lter inserts in a manner similar to H/R
experiments.
2.5. Measurement of MDA and protein content
After H/R of RBE4, PBS was removed, and 0.5 ml of fresh PBS
was added to each well. Cells were scraped o¡ and frozen immediately
in liquid nitrogen. MDA content of the samples was determined ac-
cording to [20] using HPLC (Shimadzu LC-10A chromatograph with
RF-10A £uorescence detector). Protein content was measured by a
modi¢ed Lowry procedure [21] using a Beckman spectrophotometer
DU 640.
2.6. Determination of permeability coe⁄cient of Na-£uorescein
After incubation of cocultures PBS of ¢lter inserts was replaced by
2 ml Na-£uorescein (50 WM, Molecular Probes) in PBS. Filters were
put into a 6-well plate containing 2 ml of PBS. After 10 min of
incubation, £uorescence (Vexc = 488 nm, Vem = 512 nm) was measured
in the donor and receptor chambers. The permeability coe⁄cient was
calculated according to [22].
2.7. Measurement of nitric oxide concentrations
cNO concentrations were measured by ozone-mediated chemilumi-
nescence using a Sievers 270B analyzer (purge vessel mode). The ana-
lyzer was calibrated by aliquots of sodium nitrite solutions added to
acidi¢ed potassium iodide [23]. 100 Wl aliquots of cNO solution were
injected into the purge vessel. In order to estimate steady-state con-
centrations of cNO during H/R experiments using SNAP, 100 Wl ali-
quots were taken from ¢lter inserts after 10 min of hypoxia and after
60 min of hypoxia followed by 10 min of reoxygenation and injected
into the purge vessel.
3. Results
The permeability coe⁄cient of £uorescein was 0.8^2U1033
cm/min before any treatment. The permeability increased dra-
matically after 60 min hypoxia and 30 min reoxygenation,
indicating strong disruption of the barrier; normoxic control
did not show considerable increase in permeability. Addition
of SNAP, authentic cNO and SOD during H/R strongly at-
tenuated the changes in the permeability of £uorescein (Fig.
1). One day old SNAP solutions were not protective (data not
shown) supporting the assumption that SNAP protects BBB
via the release of nitric oxide. Steady-state concentrations of
cNO in experiments with SNAP (¢nal concentration 30 WM),
measured after 10 min of hypoxia and after 60 min of hypoxia
followed by 10 min of reoxygenation, were approximately 300
nM and 200 nM, respectively.
Addition of SNAP or cNO to normoxic controls did not
cause disruption of the BBB at the concentrations used in
H/R experiments, however, severe disruption was observed
at 150 WM of SNAP (Fig. 2A) and at more than 24 WM of
cNO solution (Fig. 2B).
RBE4 monolayers were used to investigate the e¡ect of cNO
or SNAP on the formation of MDA induced by H/R. No
signi¢cant change in the MDA level was observed after 60
min of hypoxia and 30 min of reoxygenation (data not
shown). MDA content was approximately doubled (as com-
pared to the normoxic control) after longer-lasting hypoxia
and reoxygenation (120 and 60 min). Addition of authentic
cNO (6 WM) or SNAP (30 and 60 WM) to the incubation
solution during reoxygenation completely prevented the in-
crease in MDA content (Fig. 3). As shown in Fig. 3, neither
authentic cNO nor SNAP alone had any e¡ect on the MDA
content in the normoxic control.
In order to investigate the involvement of cNO/sGC signal
transduction pathway in e¡ects of cNO on BBB, the presence
of sGC mRNA was investigated in cells of BBB by RT-PCR.
While there is a clear expression of K1/L1 subunits of sGC in
rat astrocytes, no expression of sGC mRNA subunits was
found in RBE4 (Fig. 4). However, expression of K1/L1 sGC
subunits occurs in primary cultures of rat brain capillary en-
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Fig. 1. Attenuation of hypoxia/reoxygenation-induced increase in
permeability of £uorescein through a cell culture model of BBB by
SNAP (30 WM), authentic cNO (6 WM) and SOD (50 U/ml). The
BBB model was subjected to 60 min hypoxia and 30 min reoxygena-
tion. SNAP was added at 0 and 30 min of hypoxia and at 0 min of
reoxygenation. cNO was added at 0, 20 and 40 min of hypoxia and
at 0, 10 and 20 min of reoxygenation. 100% refers to permeability
coe⁄cients obtained immediately after exchange of cell culture me-
dium by PBS. Cumulative concentrations are shown (mean þ
S.E.M., n = 5^7; 3P6 0.05 versus normoxia; *P6 0.05 versus hy-
poxia).
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dothelial cells. Expression of K2/L2 subunits was not observed
in any cell type investigated (data not shown).
4. Discussion
Disruption of the BBB occurs under various pathological
conditions, such as ischemia/reperfusion [24] leading to an
increased cerebrovascular permeability with subsequent devel-
opment of tissue edema [25]. Cell culture models of BBB have
been applied to study the mechanisms of pathological proc-
esses, such as H/R [10], and speci¢c aspects of barrier func-
tion, such as transport of substances through BBB [26].
The BBB model (using RBE4) provides characteristic fea-
tures of the BBB, such as low permeability coe⁄cient for
£uorescein which is known to be not permeable into the brain.
H/R results in a strong increase in £uorescein permeability
indicating opening of BBB. Interestingly, there is almost no
disruption of BBB by H/R in the presence of SOD. This is
consistent with the observation of Terada [27] that the release
of superoxide is the major source of membrane damage in
bovine arterial endothelial cell under H/R. As SOD does
not penetrate into cells, one may assume that superoxide re-
leased from the cells accounts for the BBB disruption under
H/R, or that extracellular SOD may e¡ectively decrease the
intracellular superoxide concentration.
The mechanism of superoxide-mediated opening of BBB
under H/R is not known. Very recently, the decisive role of
superoxide radical has been shown in the post-hypoxic actin
rearrangement in macrovascular endothelial cells [28]. The
potential role of cytoskeleton has been reported in the dis-
turbance of the endothelial barrier function induced by hy-
poxia [29] and by thrombin administration [30]. Therefore, it
is probable that superoxide produced by H/R in£uences the
state of the cytoskeleton and, consequently, cellular shape,
opening paracellular pathways and increasing permeability.
There are complex mechanisms conceivable for the ob-
served protection of the post-hypoxic BBB by cNO. cNO reg-
ulates many cellular processes via activation of sGC [1]. How-
ever, in contrast to astrocytes and primary rat brain
endothelial cells, sGC mRNA has not been found in RBE4
in this study, suggesting that a cNO-induced cGMP pathway
cannot be activated. The lack of sGC activity in RBE4 was
also observed by other authors [31]. cNO may in£uence the
transmembrane ion current in a cellular model of BBB [32].
Roussin’s black salt (cNO donor compound) has been found
to disturb a macrovascular endothelial barrier in a reversible
manner [33]. The data presented here also suggest that rela-
tively high doses of cNO open the barrier. In addition, there is
no e¡ect of SNAP or cNO on the tightness of BBB at con-
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Fig. 3. E¡ect of SNAP or authentic cNO on the accumulation of
MDA induced by hypoxia/reoxygenation in RBE4 cells. RBE4
monolayers were subjected to 120 min of hypoxia followed by 60
min reoxygenation. Solutions of SNAP were added at 0, 20 and 40
min of reoxygenation. Solutions of cNO were added every 10 min of
reoxygenation starting from 0 min. Cumulative concentrations are
shown (mean þ S.E.M., n = 4; 3P6 0.001 versus normoxia;
*P6 0.001 versus hypoxia).
Fig. 2. In£uence of di¡erent concentrations of SNAP (A) or authen-
tic cNO (B) on the permeability of the BBB model under normoxic
conditions (¢lters with rat brain endothelial cells were put in PBS
for 90 min). Solutions of SNAP or cNO were added as described
for Fig. 1. Cumulative concentrations are shown (mean þ S.E.M.,
n = 4).
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centrations used for hypoxia/reoxygenation experiments in the
normoxic control.
The protective e¡ect of cNO may also be due to a scaveng-
ing of superoxide and/or peroxyl radicals since the corre-
sponding rate constants of the reactions between these radi-
cals are di¡usion-controlled [34]. One possible mechanism of
cellular protection against reactive oxygen species by cNO is
the termination of the chain reaction of lipid peroxidation by
scavenging peroxyl radicals [6]. cNO has been reported to
prevent both Cu2-induced lipid peroxidation in low-density
lipoproteins [5] and radical-induced accumulation of lipid hy-
droperoxides in phosphatidylcholine liposomes [35]. The ap-
pearance of MDA is a late event in lipid peroxidation [36]
since two double bonds must be broken in the same fatty
acid chain to release MDA. This is consistent with the data
presented here since MDA accumulation occurs later than
disruption of BBB. Nevertheless, we also observed a strong
protective e¡ect of cNO on H/R-induced MDA accumulation.
As it is known that addition of SOD inhibits lipid peroxida-
tion [37] and barrier opening [10] in post-hypoxic endothelial
cells, cNO exerts protective properties similar to SOD under
H/R of endothelial cells.
In conclusion, this study demonstrates the protective e¡ect
of nitric oxide on H/R-induced increase in blood-brain barrier
permeability and lipid peroxidation. We suggest that the ob-
served protection at the molecular and functional level is due
to scavenging of oxygen free radicals by cNO.
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